Literature DB >> 28775074

Stasis Promotes Erythrocyte Adhesion to von Willebrand Factor.

Michel W J Smeets1, Marjon J Mourik2, Hans W M Niessen2, Peter L Hordijk2.   

Abstract

OBJECTIVE: Venous thromboembolism is a major contributor to global disease burden. Leukocytes and platelets initiate thrombogenesis on blood stasis and initiate the formation of a fibrin, VWF (von Willebrand factor), and neutrophil extracellular trap scaffold for erythrocytes. However, there is little knowledge on how erythrocytes become stably incorporated into this scaffold. Recently, we described the adhesion of calcium-loaded erythrocytes to endothelial-derived VWF strings. Because VWF is part of the scaffold of venous thrombi, we questioned whether reduced flow or stasis promotes the adhesion of normal erythrocytes to VWF and whether venous thrombi show evidence of erythrocyte-VWF interactions. APPROACH AND
RESULTS: In the present work, we perfused, under controlled shear conditions, washed, normal erythrocytes over surface-immobilized plasma and extracellular matrix proteins and showed that normal erythrocytes specifically bind to VWF. The interaction between erythrocytes and VWF significantly increased when the wall shear stress was reduced. Next, we investigated whether erythrocyte-VWF interactions support the structure of venous thrombi. High-resolution immunofluorescence imaging of human venous thrombi showed a striking pattern between erythrocytes, VWF, and fibrin, which suggests that VWF plays a supporting role, linking erythrocytes to fibrin in the thrombus.
CONCLUSIONS: Our data suggest that erythrocyte retention in venous thrombi is mediated by erythrocyte-VWF or erythrocyte-VWF-fibrin interactions. Targeting erythrocyte retention could be a new strategy in the treatment or prevention of venous thrombosis.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  blood platelets; erythrocytes; fibrin; venous thrombosis; von Willebrand factor

Mesh:

Substances:

Year:  2017        PMID: 28775074     DOI: 10.1161/ATVBAHA.117.309885

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  16 in total

Review 1.  Thrombotic Regulation From the Endothelial Cell Perspectives.

Authors:  Miao Wang; Huifeng Hao; Nicholas J Leeper; Liyuan Zhu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-06       Impact factor: 8.311

2.  When Flow Goes Slow, von Willebrand Factor Can Bind Red Blood Cells.

Authors:  Scott L Diamond
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-09       Impact factor: 8.311

Review 3.  Red blood cells: the forgotten player in hemostasis and thrombosis.

Authors:  J W Weisel; R I Litvinov
Journal:  J Thromb Haemost       Date:  2019-01-07       Impact factor: 5.824

4.  VWF (von Willebrand Factor) Is Not Required for Red Blood Cell Retention in Clots in Mice.

Authors:  Lori A Holle; Dougald M Monroe; Alisa S Wolberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-06-25       Impact factor: 8.311

Review 5.  Biomaterials-Mediated Tumor Infarction Therapy.

Authors:  Shizheng Tong; Wei Zhao; Duoyi Zhao; Weilin Zhang; Zhiyu Zhang
Journal:  Front Bioeng Biotechnol       Date:  2022-06-09

6.  Reporting Sex and Sex Differences in Preclinical Studies.

Authors:  Hong S Lu; Ann Marie Schmidt; Robert A Hegele; Nigel Mackman; Daniel J Rader; Christian Weber; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

7.  Immunohistological Evaluation of Von Willebrand Factor in the Left Atrial Endocardium and Atrial Thrombi from Cats with Cardiomyopathy.

Authors:  Wan-Ching Cheng; Lois Wilkie; Tsumugi Anne Kurosawa; Melanie Dobromylskyj; Simon Lawrence Priestnall; Virginia Luis Fuentes; David J Connolly
Journal:  Animals (Basel)       Date:  2021-04-26       Impact factor: 2.752

8.  High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages.

Authors:  Willianne Hoepel; Hung-Jen Chen; Chiara E Geyer; Sona Allahverdiyeva; Xue D Manz; Steven W de Taeye; Jurjan Aman; Lynn Mes; Maurice Steenhuis; Guillermo R Griffith; Peter I Bonta; Philip J M Brouwer; Tom G Caniels; Karlijn van der Straten; Korneliusz Golebski; René E Jonkers; Mads D Larsen; Federica Linty; Jan Nouta; Cindy P A A van Roomen; Frank E H P van Baarle; Cornelis M van Drunen; Gertjan Wolbink; Alexander P J Vlaar; Godelieve J de Bree; Rogier W Sanders; Lisa Willemsen; Annette E Neele; Diederik van de Beek; Theo Rispens; Manfred Wuhrer; Harm Jan Bogaard; Marit J van Gils; Gestur Vidarsson; Menno de Winther; Jeroen den Dunnen
Journal:  Sci Transl Med       Date:  2021-05-11       Impact factor: 17.956

Review 9.  Red Blood Cells: Chasing Interactions.

Authors:  Virginia Pretini; Mischa H Koenen; Lars Kaestner; Marcel H A M Fens; Raymond M Schiffelers; Marije Bartels; Richard Van Wijk
Journal:  Front Physiol       Date:  2019-07-31       Impact factor: 4.566

10.  Lysis of cold-storage-induced microvascular obstructions for ex vivo revitalization of marginal human kidneys.

Authors:  Jenna R DiRito; Sarah A Hosgood; Melanie Reschke; Claire Albert; Laura G Bracaglia; John R Ferdinand; Benjamin J Stewart; Christopher M Edwards; Anand G Vaish; Sathia Thiru; David C Mulligan; Danielle J Haakinson; Menna R Clatworthy; W Mark Saltzman; Jordan S Pober; Michael L Nicholson; Gregory T Tietjen
Journal:  Am J Transplant       Date:  2020-07-05       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.